Landscape Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,226
Closed -$1.59M 910
2026
Q1
$1.59M Buy
3,226
+1,087
+51% +$590K 0.1% 298
2025
Q4
$1.24M Buy
+2,139
New +$1.21M 0.08% 324
2025
Q3
Sell
-5,654
Closed -$2.29M 822
2025
Q2
$2.29M Buy
+5,654
New +$2.36M 0.18% 175
2025
Q1
Sell
-1,490
Closed -$775K 865
2024
Q4
$775K Buy
1,490
+1,110
+292% +$610K 0.08% 317
2024
Q3
$235K Buy
+380
New +$225K 0.02% 549
2024
Q2
Sell
-2,971
Closed -$1.73M 892
2024
Q1
$1.73M Buy
+2,971
New +$1.67M 0.15% 182
2019
Q4
Sell
-2,379
Closed -$693K 824
2019
Q3
$693K Buy
+2,379
New +$681K 0.05% 333

Other funds holding TMO

Landscape Capital Management's TMO Position: Q2 2026 in Review

Landscape Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 3,226 shares — an estimated $1.59M sold.

Landscape Capital Management first reported a position in TMO in Q3 2019 and held it in 7 quarters. The position peaked at $2.29M in Q2 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Landscape Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Landscape Capital Management sold 3,226 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.59M.
  • Landscape Capital Management first reported a position in Thermo Fisher Scientific in Q3 2019 and held it in 7 quarters.
  • Landscape Capital Management's Thermo Fisher Scientific position peaked at $2.29M in Q2 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.